Air travel during pregnancy has not been shown to increase the rate of miscarriage in pregnant women, according to the Motherisk Program at Toronto's Hospital for Sick Children.
Santhera Pharmaceuticals is introducing Catena for the symptomatic management of patients with Friedreich's ataxia, which is a rare, progressive neuromuscular disease.
In October, Novartis expects to launch Tasigna for the treatment of chronic myeloid leukemia in adults who have developed resistance or intolerance to at least one prior therapy, including imatinib.
